Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey

Basit Öğe Kaydı
dc.authoridÖrnek, Ender/0000-0002-5233-8658
dc.authoridKilickap, Mustafa/0000-0001-7628-700X
dc.authoridDural, Muhammet/0000-0001-7227-8114
dc.authoridKAYIKCIOGLU, MERAL/0000-0003-3692-5227
dc.authoridMert, Kadir Ugur/0000-0002-1331-5365
dc.authoridince, orhan/0000-0001-6413-6407
dc.authoridOzkan, Eyup/0000-0003-0792-628X
dc.authorwosidÖrnek, Ender/AAI-2423-2019
dc.authorwosidKilickap, Mustafa/AAQ-5321-2020
dc.authorwosidDural, Muhammet/A-3190-2019
dc.authorwosidKAYIKCIOGLU, MERAL/B-1486-2018
dc.authorwosidMert, Kadir Ugur/D-6727-2016
dc.authorwosidince, orhan/KDN-5601-2024
dc.authorwosidOzkan, Eyup/IZP-6723-2023
dc.contributor.authorErol, Mustafa Kemal
dc.contributor.authorKayikcioglu, Meral
dc.contributor.authorKilickap, Mustafa
dc.contributor.authorArin, Can Baba
dc.contributor.authorKurt, Ibrahim Halil
dc.contributor.authorAktas, Ibrahim
dc.contributor.authorGunes, Yilmaz
dc.date.accessioned2024-06-12T10:50:35Z
dc.date.available2024-06-12T10:50:35Z
dc.date.issued2020
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The TURKMI registry is designed to provide insight into the characteristics, management from symptom onset to hospital discharge, and outcome of patients with acute myocardial infarction (MI) in Turkey. We report the baseline and clinical characteristics of the TURKMI population. Methods: The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of percutaneous coronary intervention selected from each EuroStat NUTS region in Turkey according to population sampling weight, prioritized by the number of hospitals in each region. All consecutive patients with acute MI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018 and November 16, 2018. Results: A total of 1930 consecutive patients (mean age, 62.0 +/- 13.2 years; 26.1% female) with a diagnosis of acute MI were prospectively enrolled. More than half of the patients were diagnosed with non-ST elevation MI (61.9%), and 38.1% were diagnosed with ST elevation MI. Coronary angiography was performed in 93.7% and, percutaneous coronary intervention was performed in 73.2% of the study population. Fibrinolytic therapy was administered to 13 patients (0.018%). Aspirin was prescribed in 99.3% of the patients, and 94% were on dual antiplatelet therapy at the time of discharge. Beta blockers were prescribed in 85.0%, anti-lipid drugs in 96.3%, angiotensin converting enzyme inhibitors in 58.4%, and angiotensin receptor blockers in 7.9%. Comparison with European countries revealed that TURKMI patients experienced MI at younger ages compared with patients in France, Switzerland, and the United Kingdom. The most prevalent risk factors in the TURKMI population were hypercholesterolemia (60.2%), hypertension (49.5%), smoking (48.8%), and diabetes (37.9%). Conclusion: The nation-wide TURKMI registry revealed that hypercholesterolemia, hypertension, and smoking were the most prevalent risk factors. TURKMI patients were younger compared with patients in European Countries. The TURKMI registry also confirmed that current treatment guidelines are largely adopted into clinical cardiology practice in Turkey in terms of antiplatelet, anti-ischemic, and anti-lipid therapy.en_US
dc.description.sponsorshipTurkish Society of Cardiology; Astra-Zeneca Companyen_US
dc.description.sponsorshipTURKMI is an investigator-initiated study sponsored by the Turkish Society of Cardiology that receives major funding from Astra-Zeneca Company for this project.en_US
dc.identifier.doi10.14744/AnatolJCardiol.2020.69696
dc.identifier.endpage53en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue1en_US
dc.identifier.pmid32628144en_US
dc.identifier.scopus2-s2.0-85088210952en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage43en_US
dc.identifier.trdizinid368021en_US
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2020.69696
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/368021
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18061
dc.identifier.volume24en_US
dc.identifier.wosWOS:000546928100013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofAnatolian Journal Of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAcute Myocardial Infarctionen_US
dc.subjectRegistryen_US
dc.subjectTurkeyen_US
dc.subjectCoronary Artery Diseaseen_US
dc.subjectTerm Mortalityen_US
dc.subjectManagementen_US
dc.subjectOutcomesen_US
dc.subjectElevationen_US
dc.titleBaseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu